Designing a Synthetic Lethality Screen

A single-arm screen ranks dependencies. An interaction needs two arms.

The design decision that comes first

DesignWhat it can findWhat it cannot
Single arm, one backgroundDependencies in that backgroundInteractions — there is no second state
Two arms, isogenic pairInteractions with the edited geneInteractions with other genotypes
Panel with genotype stratificationGenotype-associated sensitivityCausation; confounded by lineage
Two-arm panelBoth, at higher costStill needs validation

The most common error is running a single-arm screen in a knockout background and calling the hits "synthetic lethal". A hit in that design is a gene required in the knockout; whether it is also required in the wild type was not measured.

Two-arm versus interaction scoring

A genetic interaction is defined by comparing the double perturbation with the expectation from the two singles.

QuantityMeaningRequirement
Fitness(gene X, WT background)Single perturbation effectArm 1
Fitness(gene X, mutant background)Combined effectArm 2
Expected (multiplicative or additive)Null modelExplicitly stated
Interaction scoreObserved − expectedBoth arms, matched conditions

Important distinction. Multiplicative and additive null models give different answers, and the choice should be stated. For fitness readouts, the multiplicative model is conventional; for a score that saturates at zero viability, it is not appropriate and a different transformation is needed.

Library

LibraryGenesGuides per geneUse
Genome-wide~19,0004–6Hypothesis-free
Druggable / metabolic subset2,000–3,0004–6Cheaper, higher coverage per gene
Focused pathway100–5006–10Mechanism, epistasis
Dual-guide (pairwise)Combinatorial—Direct interaction mapping, very large

For most metabolic questions the subset library is the better choice: the pathway is known, the question is which node interacts, and the coverage per gene is higher at the same cost.

Coverage arithmetic

ParameterValueConsequence
Genes2,000—
Guides per gene510,000 guides
Cells per guide at selection3003 × 10⁶ cells
Transduction efficiency30%~1 × 10⁷ cells at transduction
Doublings over the window8Coverage falls unevenly across guides
Reads per guide2002 × 10⁶ reads per sample

The third and fifth rows are where screens fail silently. Cells per guide at selection is not cells per guide at transduction, and a long window lets fast-growing clones dominate the baseline.

Readout and window

ReadoutDetectsWindow
Viability selectionLethality, strong sickness14–21 days
Fluorescence sortingMarker-linked phenotype5–10 days
Expression readout (RNA)Pathway output1–3 days
ImagingMorphology, localisationFixed endpoint

A viability screen needs enough time for the interaction to manifest and short enough for coverage to survive. For metabolic interactions, which are often graded, the window determines whether the effect is detectable at all: too short and it is absent, too long and it is masked by adaptation.

Caveat on adaptation. Cells with a partial fitness defect can acquire compensatory mutations over three weeks. A hit that disappears on re-testing in a fresh background may have been an adaptation, not an interaction.

Scoring and statistics

  • • Normalise per sample for library representation before comparison.
  • • Use the negative-control distribution to set the null, not the bulk of guides.
  • • Model the over-dispersion. Guide-level counts are not Poisson; a negative-binomial or empirical-Bayes approach is standard.
  • • Report effect size with the confidence interval. A rank is not a result.
  • • Correct for the number of hypotheses, and state which correction.

Readout note. The output of a screen is a ranked list with uncertainty, not a set of hits. The cut-off is a decision about the follow-up budget, and it should be described as such.

Validation, in order

StepTestRules out
1Individual knockout, two guidesGuide-specific off-target
2Second, non-overlapping guidePosition effects
3Rescue with a resistant cDNAOn-target activity
4Compound, if one existsPhenotype specific to CRISPR
5Re-test in a fresh isogenic pairClone artefacts, adaptation
6In vivo, if the claim is translationalCulture-specific interaction

Steps 1–3 eliminate most false positives and are cheap. Step 5 is the one that catches the failure mode specific to long screens.

Failures that recur

  • • Single-arm screen labelled synthetic lethal.
  • • Null model unstated. Multiplicative and additive give different hits.
  • • Coverage computed at selection only. Transduction needs several fold more cells.
  • • Baseline library not sequenced. Drift is unattributable.
  • • Effect size omitted. Rank alone cannot be reproduced.
  • • Adaptation mistaken for interaction. Re-test in a fresh background.
  • • Guide-level off-target not excluded. Two guides is the minimum.

Where this connects

  • • Metabolic synthetic lethality article supplies the definitions and the evidence standard this design serves.
  • • Tumour dependency article supplies the target-validation gates that follow a screen.
  • • Amino acid pillar supplies the methionine and one-carbon logic behind the canonical MTAP–MAT2A interaction.

Scientific interpretation and experimental design

  • • Two arms or it is not an interaction.
  • • State the null model.
  • • Compute coverage at transduction.
  • • Sequence the baseline library.
  • • Report effect size and interval.
  • • Validate with two guides and a rescue.
  • • Re-test in a fresh background to exclude adaptation.

Selected references for further reading

  • • Hart T, et al. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Molecular Systems Biology. 2014;10:733.
  • • Horlbeck MA, et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife. 2016;5:e19760.
  • • Li W, et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biology. 2015;16:281.
  • • Kryukov GV, et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science. 2016;351:1214–1218.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: